ANGELA JONES: Open Payments
NPI 1437402856 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 39 payments from 11 companies in 2025. Trend: 2023 $1,087 · 2024 $1,070 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $257 |
| ABBVIE INC. | 7 | $175 |
| E.R. Squibb & Sons, L.L.C. | 4 | $166 |
| Alkermes, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, COBENFY, ARISTADA, SPRAVATO, FANAPT, REXULTI, Auvelity.
Industry payments across MO — which companies pay providers there.
